Bottom line
What is VNVAX's expense ratio?
VNVAX's expense ratio is 1.1%, or about $110 a year on every $10,000 invested. That is more expensive than 69% of mid-cap funds we track (median 0.88%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Jul 1, 2026
VNVAX fee table
| Net expense ratio | 1.1% |
|---|---|
| Gross expense ratio | 1.27% |
| Management fee | 0.75% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.27% |
| Fee waiver / reimbursement | 0.17% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Jul 1, 2026
What VNVAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| VNVAX | $681 | $925 | $1,203 | $1,994 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.1% expense ratio costs roughly $60,400 in lost growth, versus about $49,300 for the median mid-cap fund (0.88%).